Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The results of the Evaluation of LIXisenatide in Acute coronary syndrome (ELIXA) trial, the first cardiovascular outcomes trial for the short-acting GLP-1 RA lixisenatide, were also published recently [52]
Acetylcysteine and either a proton pump inhibitor or a histamine H 2 receptor blocker should be given to all patients with acute liver failure
Patients pay about $100 to $450 a month, compared with list prices of roughly $1,000 to $1,400 for Lilly and Novo Nordisk products
Clinical trials show non-diabetic patients lose 10 to 22 percent of baseline body weight over 68 weeks, depending on dose and adherence
US$ 23.17
US$ 29.04
US$ 28.48
US$ 23.52
US$ 26.04
US$ 28.43
US$ 22.96
